指南与共识神经肿瘤

神经外科医师大会关于前庭神经鞘瘤手术切除治疗患者的系统综述与循证指南

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Surgical Resection for the Treatment of Patients With Vestibular Schwannomas.
指南 / 共识 · Neurosurgery · 2018-01-01

该指南由神经外科医师大会制定,针对前庭神经鞘瘤手术切除的11个临床问题给出推荐。多数问题证据不足,仅肿瘤大小与听力丧失风险、小肿瘤听力保留手术、三叉神经痛缓解及放疗后手术难度等给出Level 3推荐。

要点

  • 可服务听力存在时,中颅窝与乙状窦后入路在完全切除和面神经保留上无足够证据支持优劣。
  • 不可服务听力存在时,乙状窦后与经迷路入路在完全切除和面神经保留上无足够证据支持优劣。
  • 肿瘤较大者应告知可服务听力丧失风险高于平均水平(Level 3)。

核心结论

  • 多数手术决策问题证据不足,仅少数问题给出Level 3推荐。

研究设计与样本

  • 神经外科医师大会制定的系统综述与循证指南,针对前庭神经鞘瘤手术切除的11个问题。

主要发现

  • 可服务听力存在时,中颅窝与乙状窦后入路在完全切除和面神经保留上证据不足。
  • 不可服务听力存在时,乙状窦后与经迷路入路在完全切除和面神经保留上证据不足。
  • 肿瘤较大者应告知可服务听力丧失风险高于平均水平(Level 3)。
  • 小肿瘤(<1.5 cm)且术前听力良好者,可尝试经中颅窝或乙状窦后入路行听力保留手术(Level 3)。
  • 手术切除可能较立体定向放射外科更好地缓解三叉神经痛症状(Level 3)。

关键数值与推荐

  • 问题3:Level 3,肿瘤较大者应告知可服务听力丧失风险高于平均水平。
  • 问题5:Level 3,小肿瘤(<1.5 cm)且术前听力良好者,可尝试经中颅窝或乙状窦后入路行听力保留手术。
  • 问题10:Level 3,手术切除可能较立体定向放射外科更好地缓解三叉神经痛症状。
  • 问题11:Level 3,立体定向放射外科后如需显微手术切除,应告知患者部分切除和面神经功能下降的可能性增加。

临床怎么用

  • 可服务听力存在时,中颅窝或乙状窦后入路均可选择,无足够证据支持某一入路更优。
  • 不可服务听力存在时,乙状窦后或经迷路入路均可选择,无足够证据支持某一入路更优。
  • 小肿瘤(<1.5 cm)且术前听力良好者,可尝试经中颅窝或乙状窦后入路行听力保留手术(Level 3)。
  • 立体定向放射外科后如需显微手术切除,应告知患者部分切除和面神经功能下降的可能性增加(Level 3)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

QUESTION 1: What surgical approaches for vestibular schwannomas (VS) are best for complete resection and facial nerve (FN) preservation when serviceable hearing is present? RECOMMENDATION: There is insufficient evidence to support the superiority of either the middle fossa (MF) or the retrosigmoid (RS) approach for complete VS resection and FN preservation when serviceable hearing is present. QUESTION 2: Which surgical approach (RS or translabyrinthine [TL]) for VS is best for complete resection and FN preservation when serviceable hearing is not present? RECOMMENDATION: There is insufficient evidence to support the superiority of either the RS or the TL approach for complete VS resection and FN preservation when serviceable hearing is not present. QUESTION 3: Does VS size matter for facial and vestibulocochlear nerve preservation with surgical resection? RECOMMENDATION: Level 3: Patients with larger VS tumor size should be counseled about the greater than average risk of loss of serviceable hearing. QUESTION 4: Should small intracanalicular tumors (<1.5 cm) be surgically resected? RECOMMENDATION: There are insufficient data to support a firm recommendation that surgery be the primary treatment for this subclass of VSs. QUESTION 5: Is hearing preservation routinely possible with VS surgical resection when serviceable hearing is present? RECOMMENDATION: Level 3: Hearing preservation surgery via the MF or the RS approach may be attempted in patients with small tumor size (<1.5 cm) and good preoperative hearing. QUESTION 6: When should surgical resection be the initial treatment in patients with neurofibromatosis type 2 (NF2)? RECOMMENDATION: There is insufficient evidence that surgical resection should be the initial treatment in patients with NF2. QUESTION 7: Does a multidisciplinary team, consisting of neurosurgery and neurotology, provides the best outcomes of complete resection and facial/vestibulocochlear nerve preservation for patients undergoing resection of VSs? RECOMMENDATION: There is insufficient evidence to support stating that a multidisciplinary team, usually consisting of a neurosurgeon and a neurotologist, provides superior outcomes compared to either subspecialist working alone. QUESTION 8: Does a subtotal surgical resection of a VS followed by stereotactic radiosurgery (SRS) to the residual tumor provide comparable hearing and FN preservation to patients who undergo a complete surgical resection? RECOMMENDATION: There is insufficient evidence to support subtotal resection (STR) followed by SRS provides comparable hearing and FN preservation to patients who undergo a complete surgical resection. QUESTION 9: Does surgical resection of VS treat preoperative balance problems more effectively than SRS? RECOMMENDATION: There is insufficient evidence to support either surgical resection or SRS for treatment of preoperative balance problems. QUESTION 10: Does surgical resection of VS treat preoperative trigeminal neuralgia more effectively than SRS? RECOMMENDATION: Level 3: Surgical resection of VSs may be used to better relieve symptoms of trigeminal neuralgia than SRS. QUESTION 11: Is surgical resection of VSs more difficult (associated with higher facial neuropathies and STR rates) after initial treatment with SRS? RECOMMENDATION: Level 3: If microsurgical resection is necessary after SRS, it is recommended that patients be counseled that there is an increased likelihood of a STR and decreased FN function. The full guideline can be found at: https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter_8.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Hadjipanayis CG, Carlson ML, Link MJ, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Surgical Resection for the Treatment of Patients With Vestibular Schwannomas. Neurosurgery. 2018. PMID: 29309632. doi:10.1093/neuros/nyx512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。